Gary Vanasse

2.0k total citations
32 papers, 816 citations indexed

About

Gary Vanasse is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Gary Vanasse has authored 32 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 12 papers in Genetics and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Gary Vanasse's work include Erythrocyte Function and Pathophysiology (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Gary Vanasse is often cited by papers focused on Erythrocyte Function and Pathophysiology (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Gary Vanasse collaborates with scholars based in United States, Switzerland and Australia. Gary Vanasse's co-authors include Nancy Berliner, Dennis M. Willerford, Patrick Concannon, Todd S. Perlstein, Reena L. Pande, Christine M. Distèche, Adeel A. Butt, Xiaomei Ma, Matthew S. Freiberg and Yun Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Gary Vanasse

32 papers receiving 800 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gary Vanasse United States	15	299	245	223	138	132	32	816
Yuri B. Pride United States	19	434 1.5×	227 0.9×	469 2.1×	139 1.0×	85 0.6×	37	1.7k
G. Ehninger Germany	15	463 1.5×	144 0.6×	162 0.7×	170 1.2×	74 0.6×	56	859
Shinjiro Todo Japan	21	721 2.4×	88 0.4×	258 1.2×	236 1.7×	22 0.2×	79	1.4k
J Sheskin Israel	12	420 1.4×	119 0.5×	221 1.0×	82 0.6×	51 0.4×	43	893
Dorit Blickstein Israel	18	280 0.9×	199 0.8×	185 0.8×	98 0.7×	14 0.1×	47	874
Jonathan M. Keller United States	11	155 0.5×	48 0.2×	262 1.2×	117 0.8×	54 0.4×	22	610
Su‐Peng Yeh Taiwan	14	514 1.7×	175 0.7×	410 1.8×	180 1.3×	20 0.2×	65	951
Robert Delage Canada	18	400 1.3×	305 1.2×	141 0.6×	178 1.3×	7 0.1×	58	957
Sarah Bertoli France	19	780 2.6×	240 1.0×	449 2.0×	216 1.6×	58 0.4×	65	1.1k
Deepesh Lad India	14	265 0.9×	202 0.8×	125 0.6×	153 1.1×	13 0.1×	131	622

Countries citing papers authored by Gary Vanasse

Since Specialization

Citations

This map shows the geographic impact of Gary Vanasse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Vanasse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Vanasse more than expected).

Fields of papers citing papers by Gary Vanasse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Vanasse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Vanasse. The network helps show where Gary Vanasse may publish in the future.

Co-authorship network of co-authors of Gary Vanasse

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Vanasse. A scholar is included among the top collaborators of Gary Vanasse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Vanasse. Gary Vanasse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rampal, Raajit K., Maria Pinzon-Ortiz, Amritha Varshini Hanasoge Somasundara, et al.. (2021). Therapeutic Efficacy of Combined JAK1/2, Pan-PIM, and CDK4/6 Inhibition in Myeloproliferative Neoplasms. Clinical Cancer Research. 27(12). 3456–3468. 14 indexed citations

Burga, Rachel A., Kyle D. Pedro, Jacques P. Tremblay, et al.. (2021). 1008P cytoTIL15: A novel TIL therapy for melanoma with superior potency and enhanced persistence without IL2 to improve safety & efficacy and expand patient eligibility. Annals of Oncology. 32. S852–S852. 1 indexed citations

Mauro, Michael J., D.-W. Kim, Jörge E. Cortes, et al.. (2019). S884 COMBINATION OF ASCIMINIB PLUS NILOTINIB (NIL) OR DASATINIB (DAS) IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA (CML): RESULTS FROM A PHASE 1 STUDY. HemaSphere. 3(S1). 397–398. 13 indexed citations

Cortes, Jörge E., Fabian Lang, Delphine Réa, et al.. (2019). S883 COMBINATION THERAPY USING ASCIMINIB PLUS IMATINIB (IMA) IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA (CML): RESULTS FROM A PHASE 1 STUDY. HemaSphere. 3(S1). 397–397. 15 indexed citations

Jeong, Jee‐Yeong, Michelle S. Levine, Nirmalee Abayasekara, et al.. (2015). The non-peptide thrombopoietin receptor agonist eltrombopag stimulates megakaryopoiesis in bone marrow cells from patients with relapsed multiple myeloma. Journal of Hematology & Oncology. 8(1). 37–37. 11 indexed citations

Pinzon-Ortiz, Maria, Abdel Saci, Robert Schlegel, et al.. (2014). Abstract 3684: The combination of JAK inhibitor, ruxolitinib, pan-PIM inhibitor, LGH447, and CDK4/6 inhibitor, LEE011, in a preclinical mouse model of myeloproliferative neoplasia. Cancer Research. 74(19_Supplement). 3684–3684. 3 indexed citations

Mohanty, Arpan, Sebhat Erqou, Kathleen A. McGinnis, et al.. (2013). Therapy for Hepatitis C Virus Infection Increases Survival of Patients With Pretreatment Anemia. Clinical Gastroenterology and Hepatology. 11(6). 741–747.e3. 12 indexed citations

Erqou, Sebhat, Arpan Mohanty, Kathleen A. McGinnis, et al.. (2013). Hepatitis C virus treatment and survival in patients with hepatitis C and human immunodeficiency virus co‐infection and baseline anaemia. Journal of Viral Hepatitis. 20(7). 463–469. 7 indexed citations

Justice, Amy C., Matthew S. Freiberg, Russell P. Tracy, et al.. (2012). Does an Index Composed of Clinical Data Reflect Effects of Inflammation, Coagulation, and Monocyte Activation on Mortality Among Those Aging With HIV?. Clinical Infectious Diseases. 54(7). 984–994. 160 indexed citations

10.

Vanasse, Gary, Jee‐Yeong Jeong, Janet Tate, et al.. (2011). A polymorphism in the leptin gene promoter is associated with anemia in patients with HIV disease. Blood. 118(20). 5401–5408. 4 indexed citations

11.

Jeong, Jee‐Yeong, Matthew R. Silver, Aric Parnes, et al.. (2011). Resveratrol ameliorates TNFα‐mediated suppression of erythropoiesis in human CD34⁺ cells via modulation of NF‐κB signalling. British Journal of Haematology. 155(1). 93–101. 11 indexed citations

12.

Ma, Xiaomei, et al.. (2008). Prevalence of polycythemia vera and essential thrombocythemia. American Journal of Hematology. 83(5). 359–362. 65 indexed citations

13.

Parnes, Aric, Carlo Bifulco, & Gary Vanasse. (2007). A novel regimen incorporating the concomitant administration of fludarabine and alemtuzumab for the treatment of refractory adult acute lymphoblastic leukaemia: a report of three cases. British Journal of Haematology. 139(1). 164–165. 2 indexed citations

14.

Gupta, Kalpana, Ann Macintyre, Gary Vanasse, & Louise‐Marie Dembry. (2007). Trends in Prescribing β-Lactam Antibiotics for Treatment of Community-Associated Methicillin-Resistant Staphylococcus aureus Infections. Journal of Clinical Microbiology. 45(12). 3930–3934. 16 indexed citations

15.

Bifulco, Carlo, et al.. (2006). Overexpression of SOCS3 is associated with decreased survival in a cohort of patients with de novo follicular lymphoma. British Journal of Haematology. 135(1). 72–75. 15 indexed citations

16.

Doty, Raymond T., Gary Vanasse, Christine M. Distèche, & Dennis M. Willerford. (2002). The Leukemia-Associated Gene Mllt1/ENL: Characterization of a Murine Homolog and Demonstration of an Essential Role in Embryonic Development. Blood Cells Molecules and Diseases. 28(3). 407–417. 16 indexed citations

17.

Vanasse, Gary, James Halbrook, Ann C. Burgess, et al.. (1999). Genetic pathway to recurrent chromosome translocations in murine lymphoma involves V(D)J recombinase. Journal of Clinical Investigation. 103(12). 1669–1675. 82 indexed citations

18.

Vanasse, Gary, Patrick Concannon, & Dennis M. Willerford. (1999). Regulated Genomic Instability and Neoplasia in the Lymphoid Lineage. Blood. 94(12). 3997–4010. 91 indexed citations

19.

Sytkowski, Arthur J., Carl O’Hara, Gary Vanasse, et al.. (1990). Characterization of biologically active, platelet-derived growth factor-like molecules produced by murine erythroid cells in vitro and in vivo.. Journal of Clinical Investigation. 85(1). 40–46. 16 indexed citations

20.

Choi, Hye‐Seon, et al.. (1990). Purification and characterization of the erythropoietin-sensitive membrane phosphoprotein, pp43.. Journal of Biological Chemistry. 265(7). 4143–4148. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact